Key learning from the Dana-Farber Cancer Institute’s 10-year patient safety journey

Conway J, Nathan DG, Benz EJ, et al. “Key Learning from the Dana-Farber Cancer Institute’s 10-Year Patient Safety Journey.” American Society of Clinical Oncology 2006 Educational Book, 42nd Annual Meeting, June 2-6, 2006, in Atlanta, GA. 2006:615-619.

The tragic chemotherapy overdoses to Betsy Lehman and Maureen Bateman, which were discovered at the Dana-Farber Cancer Institute (DFCI) in February 1995, are well known. During the 10-year anniversary of these events, DFCI leadership assessed its patient safety learning, identifying the six most critical elements of learning.


Average Content Rating
(0 user)
Please login to rate or comment on this content.
User Comments